Article
15 April 2025 - by Dominic Duke, Madeleine Cline, David M. Liner
Medicare Part D claims show non-low income drug spending rose 43% in early 2025 versus a year earlier, while costs for other categories also accelerated.
Article
15 April 2025 - by Dominic Duke, Madeleine Cline, David M. Liner
MedIntel Insights: We give an early glimpse of Medicare Prescription Payment Plan enrollment, which had 179,000 beneficiaries participate in its first two months.
Article
15 April 2025 - by Madeleine Cline, Rachel W. Madden, Katherine M. Holcomb
In our latest trend report on Medicare Part D, we present a more detailed review of utilization and cost patterns in the individual market through year-end 2024.
Article
03 February 2025 - by Madeleine Cline, Rachel W. Madden, Katherine M. Holcomb
We look at the top-line gross cost trends in Medicare Part D, focusing on factors that stakeholders should consider as they review 2024 prescription drug data.
Article
13 December 2024 - by Madeleine Cline, Justin Harris, Jian-ya Lin, Mark F. Gruenhaupt, RPh
Medicare Part D: We highlight the changes in plan incentives and key trends in 2025 formulary coverage, along with considerations for 2026.
Article
24 October 2024 - by Jake K. Klaisner, Madeleine Cline
Analyzing data from the Centers for Medicare and Medicaid Services, we highlight key changes in the prescription drug plan market for 2025.
Article
05 September 2024 - by Katherine M. Holcomb, Madeleine Cline, Jake K. Klaisner, Jennifer Carioto, Gabriela Dieguez
We explore the implications of the 2026 maximum fair prices within Medicare price negotiation, part of a paradigm shift in Part D access and cost.
Article
06 August 2024 - by Madeleine Cline, David M. Liner
We discuss key drivers behind the increased direct subsidy for Medicare Part D due to the Inflation Reduction Act, along with implications for plan sponsors.
Article
25 June 2024 - by Madeleine Cline, Michelle (Klein) Robb, Katherine M. Holcomb
We analyze the impact of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program on Part D beneficiary out-of-pocket costs.
Article
06 March 2024 - by Madeleine Cline, Jake K. Klaisner, Ali M. Heinrich, Katherine M. Holcomb, Melanie K. Kuester
How might requiring Part D coverage for anti-obesity medications affect Medicare program costs?